These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14608735)

  • 21. Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
    Meheus F; Boelaert M; Baltussen R; Sundar S
    Trop Med Int Health; 2006 Nov; 11(11):1715-24. PubMed ID: 17054752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S; Mehta H; Suresh AV; Singh SP; Rai M; Murray HW
    Clin Infect Dis; 2004 Feb; 38(3):377-83. PubMed ID: 14727208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children.
    Apa H; Devrim İ; Bayram N; Deveci R; Demir-Özek G; Cartı ÖU
    Turk J Pediatr; 2013; 55(4):378-83. PubMed ID: 24292030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
    J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain.
    Ramos JM; Clavijo A; Moral L; Gavilan C; Salvador T; González de Dios J
    Paediatr Int Child Health; 2018 Aug; 38(3):203-208. PubMed ID: 29790825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-emergence of visceral leishmaniasis in Gujarat, India.
    Sharma U; Redhu NS; Mathur P; Singh S
    J Vector Borne Dis; 2007 Sep; 44(3):230-2. PubMed ID: 17896628
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient.
    Pandey BD; Pandey K; Kaneko O; Yanagi T; Hirayama K
    Am J Trop Med Hyg; 2009 Apr; 80(4):580-2. PubMed ID: 19346379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    Molina I; Falcó V; Crespo M; Riera C; Ribera E; Curran A; Carrio J; Diaz M; Villar del Saz S; Fisa R; López-Chejade P; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Oct; 60(4):837-42. PubMed ID: 17684055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
    Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
    Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Turk J Pediatr; 2003; 45(3):280. PubMed ID: 14696814
    [No Abstract]   [Full Text] [Related]  

  • 31. Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan.
    Babiker ZO; Davidson R; Mazinda C; Kipngetich S; Ritmeijer K
    Am J Trop Med Hyg; 2007 Apr; 76(4):689-93. PubMed ID: 17426171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importation of visceral leishmaniasis in returning Romanian workers from Spain.
    Neghina R; Neghina AM; Merkler C; Marincu I; Moldovan R; Iacobiciu I
    Travel Med Infect Dis; 2009 Jan; 7(1):35-9. PubMed ID: 19174299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Visceral leishmaniases].
    Rosenthal E; Marty P
    Rev Prat; 2004 Dec; 54(20):2211-6. PubMed ID: 15736529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First case of indigenous visceral leishmaniasis from central India.
    Dey A; Sharma U; Singh S
    Am J Trop Med Hyg; 2007 Jul; 77(1):95-8. PubMed ID: 17620636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral leishmaniasis among liver transplant recipients: an overview.
    Campos-Varela I; Len O; Castells L; Tallada N; Ribera E; Dopazo C; Vargas V; Gavaldà J; Charco R
    Liver Transpl; 2008 Dec; 14(12):1816-9. PubMed ID: 19025932
    [No Abstract]   [Full Text] [Related]  

  • 39. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil.
    Oliveira RA; Silva LS; Carvalho VP; Coutinho AF; Pinheiro FG; Lima CG; Leandro JE; Silva GB; Daher EF
    Transpl Infect Dis; 2008 Oct; 10(5):364-8. PubMed ID: 18507750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABLE: a new and improved amphotericin B for visceral leishmaniasis?
    Berman J
    Am J Trop Med Hyg; 2009 May; 80(5):689-90. PubMed ID: 19407106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.